---
title: "Novartis Holding Ag — Ownership Dossier"
canonical: https://whiteintel.dev/entity/74adf261-3d63-4ed2-9b54-a073bcceaf7d
json: https://whiteintel.dev/api/public/dossier/74adf261-3d63-4ed2-9b54-a073bcceaf7d
identifier: gb-coh:CHE-103.959.690
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Novartis Holding Ag

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:CHE-103.959.690`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/74adf261-3d63-4ed2-9b54-a073bcceaf7d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/74adf261-3d63-4ed2-9b54-a073bcceaf7d  

## Ownership & control

### Holdings / subsidiaries

- **HALEON UK HOLDINGS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/9a9412c4-bbf0-545c-b128-d5eba5dc2137

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Novartis Holding Ag**. Human view: https://whiteintel.dev/entity/74adf261-3d63-4ed2-9b54-a073bcceaf7d · Structured JSON: https://whiteintel.dev/api/public/dossier/74adf261-3d63-4ed2-9b54-a073bcceaf7d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._